Seonyang C. Park
Haeundae, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome.
Journal: British journal of haematology
Published: July 18, 2024
Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor.
Journal: Therapeutic advances in hematology
Published: April 03, 2023
Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients.
Journal: Leukemia research
Published: February 28, 2021
Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study.
Journal: In vivo (Athens, Greece)
Published: July 10, 2019
Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 10, 2019
Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation.
Journal: Blood cells, molecules & diseases
Published: September 02, 2018
Serum Free Light Chain Difference and β2 Microglobulin Levels Are Risk Factors for Thromboembolic Events in Patients With AL Amyloidosis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 17, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.
Journal: Cancer medicine
Published: November 06, 2017
Last Updated: 09/26/2026